IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0136626.html
   My bibliography  Save this article

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Author

Listed:
  • Yunda Huang
  • Dean Follmann
  • Martha Nason
  • Lily Zhang
  • Ying Huang
  • Devan V Mehrotra
  • Zoe Moodie
  • Barbara Metch
  • Holly Janes
  • Michael C Keefer
  • Gavin Churchyard
  • Merlin L Robb
  • Patricia E Fast
  • Ann Duerr
  • M Juliana McElrath
  • Lawrence Corey
  • John R Mascola
  • Barney S Graham
  • Magdalena E Sobieszczyk
  • James G Kublin
  • Michael Robertson
  • Scott M Hammer
  • Glenda E Gray
  • Susan P Buchbinder
  • Peter B Gilbert

Abstract

Background: Three phase 2b, double-blind, placebo-controlled, randomized efficacy trials have tested recombinant Adenovirus serotype-5 (rAd5)-vector preventive HIV-1 vaccines: MRKAd5 HIV-1 gag/pol/nef in Step and Phambili, and DNA/rAd5 HIV-1 env/gag/pol in HVTN505. Due to efficacy futility observed at the first interim analysis in Step and HVTN505, participants of all three studies were unblinded to their vaccination assignments during the study but continued follow–up. Rigorous meta-analysis can provide crucial information to advise the future utility of rAd5-vector vaccines. Methods: We included participant-level data from all three efficacy trials, and three Phase 1–2 trials evaluating the HVTN505 vaccine regimen. We predefined two co-primary analysis cohorts for assessing the vaccine effect on HIV-1 acquisition. The modified-intention-to-treat (MITT) cohort included all randomly assigned participants HIV-1 uninfected at study entry, who received at least the first vaccine/placebo, and the Ad5 cohort included MITT participants who received at least one dose of rAd5-HIV vaccine or rAd5-placebo. Multivariable Cox regression models were used to estimate hazard ratios (HRs) of HIV-1 infection (vaccine vs. placebo) and evaluate HR variation across vaccine regimens, time since vaccination, and subgroups using interaction tests. Findings: Results are similar for the MITT and Ad5 cohorts; we summarize MITT cohort results. Pooled across the efficacy trials, over all follow-up time 403 (n = 224 vaccine; n = 179 placebo) of 6266 MITT participants acquired HIV-1, with a non-significantly higher incidence in vaccine recipients (HR 1.21, 95% CI 0.99–1.48, P = 0.06). The HRs significantly differed by vaccine regimen (interaction P = 0.03; MRKAd5 HR 1.41, 95% CI 1.11–1.78, P = 0.005 vs. DNA/rAd5 HR 0.88, 95% CI 0.61–1.26, P = 0.48). Results were similar when including the Phase 1–2 trials. Exploratory analyses based on the efficacy trials supported that the MRKAd5 vaccine-increased risk was concentrated in Ad5-positive or uncircumcised men early in follow-up, and in Ad5-negative or circumcised men later. Overall, MRKAd5 vaccine-increased risk was evident across subgroups except in circumcised Ad5-negative men (HR 0.97, 95% CI 0.58−1.63, P = 0.91); there was little evidence that the DNA/rAd5 vaccine, that was tested in this subgroup, increased risk (HR 0.88, 95% CI 0.61–1.26, P = 0.48). When restricting the analysis of Step and Phambili to follow-up time before unblinding, 114 (n = 65 vaccine; n = 49 placebo) of 3770 MITT participants acquired HIV-1, with a non-significantly higher incidence in MRKAd5 vaccine recipients (HR 1.30, 95% CI 0.89–1.14, P = 0.18). Interpretation and Significance: The data support increased risk of HIV-1 infection by MRKAd5 over all follow-up time, but do not support increased risk of HIV-1 infection by DNA/rAd5. This study provides a rationale for including monitoring plans enabling detection of increased susceptibility to infection in HIV-1 at-risk populations.

Suggested Citation

  • Yunda Huang & Dean Follmann & Martha Nason & Lily Zhang & Ying Huang & Devan V Mehrotra & Zoe Moodie & Barbara Metch & Holly Janes & Michael C Keefer & Gavin Churchyard & Merlin L Robb & Patricia E Fa, 2015. "Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-19, September.
  • Handle: RePEc:plo:pone00:0136626
    DOI: 10.1371/journal.pone.0136626
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136626
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136626&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0136626?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Lang Wu & Peter B. Gilbert, 2002. "Flexible Weighted Log-Rank Tests Optimal for Detecting Early and/or Late Survival Differences," Biometrics, The International Biometric Society, vol. 58(4), pages 997-1004, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lee, Seung-Hwan & Lee, Eun-Joo & Omolo, Bernard Oguna, 2008. "Using integrated weighted survival difference for the two-sample censored data problem," Computational Statistics & Data Analysis, Elsevier, vol. 52(9), pages 4410-4416, May.
    2. Grzegorz Wyłupek, 2021. "A permutation test for the two-sample right-censored model," Annals of the Institute of Statistical Mathematics, Springer;The Institute of Statistical Mathematics, vol. 73(5), pages 1037-1061, October.
    3. Lee, Seung-Hwan, 2007. "On the versatility of the combination of the weighted log-rank statistics," Computational Statistics & Data Analysis, Elsevier, vol. 51(12), pages 6557-6564, August.
    4. Lee Seung-Hwan & Lee Eun-Joo, 2020. "A weighted log-rank test for comparing two survival curves," Monte Carlo Methods and Applications, De Gruyter, vol. 26(3), pages 253-262, September.
    5. Takumi Saegusa & Chongzhi Di & Ying Qing Chen, 2014. "Hypothesis testing for an extended cox model with time-varying coefficients," Biometrics, The International Biometric Society, vol. 70(3), pages 619-628, September.
    6. Vinh Q. Nguyen & Daniel L. Gillen, 2017. "Censoring-robust estimation in observational survival studies: Assessing the relative effectiveness of vascular access type on patency among end-stage renal disease patients," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 9(2), pages 406-430, December.
    7. Seung-Hwan Lee, 2021. "Weighted Log-Rank Statistics for Accelerated Failure Time Model," Stats, MDPI, vol. 4(2), pages 1-11, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0136626. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.